The global life science chemical and instrumentation market size accounted for USD 61.48 billion in 2024, grew to USD 65.6 billion in 2025 and is projected to surpass around USD 117.59 billion by 2034, representing a healthy CAGR of 6.70% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Life Science Chemical and Instrumentation Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Life Science Chemical and Instrumentation Market Revenue and Volume, by Technology, 2024-2034
8.1.1. Spectroscopy
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Chromatography
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
8.1.3. Flow Cytometry
8.1.3.1. Market Revenue and Volume Forecast (2021-2034)
8.1.4. NGS
8.1.4.1. Market Revenue and Volume Forecast (2021-2034)
8.1.5. PCR
8.1.5.1. Market Revenue and Volume Forecast (2021-2034)
8.1.6. Microscopy
8.1.6.1. Market Revenue and Volume Forecast (2021-2034)
9.1. Life Science Chemical and Instrumentation Market Revenue and Volume, by End User, 2024-2034
9.1.1. Hospital and Diagnostic centers
9.1.1.1. Market Revenue and Volume Forecast (2021-2034)
9.1.2. Pharmaceutical and Biotechnology companies
9.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1.3. Contract Research Organizations and Research institutes
9.1.3.1. Market Revenue and Volume Forecast (2021-2034)
10.1. North America
10.1.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.1.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.1.3. U.S.
10.1.3.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.1.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.1.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2. Europe
10.2.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.2.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2.3. UK
10.2.3.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.2.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2.4. Germany
10.2.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.2.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2.5. France
10.2.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.2.5.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.2.6.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3. APAC
10.3.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3.3. India
10.3.3.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.3.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3.4. China
10.3.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.3.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3.5. Japan
10.3.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.3.5.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.3.6.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4. MEA
10.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4.3. GCC
10.4.3.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.4.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4.4. North Africa
10.4.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.4.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4.5. South Africa
10.4.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.4.5.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.4.6.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.5. Latin America
10.5.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.5.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.5.3. Brazil
10.5.3.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.5.3.2. Market Revenue and Volume Forecast, by End User (2021-2034)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Volume Forecast, by Technology (2021-2034)
10.5.4.2. Market Revenue and Volume Forecast, by End User (2021-2034)
11.1. Agile Technologies Inc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. PerkinElmer Inc
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Bruker Corporation
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Thermo Fisher Scientific Inc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Water Corporation
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample